Diver Elisabeth J, Rauh-Hain J Alejandro, Del Carmen Marcela G
Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Yawkey 9E Boston, MA 02114, USA.
Int J Surg Oncol. 2012;2012:693535. doi: 10.1155/2012/693535. Epub 2012 Jun 10.
Total pelvic exenteration (PE) is a radical operation, involving en bloc resection of pelvic organs, including reproductive structures, bladder, and rectosigmoid. In gynecologic oncology, it is most commonly indicated for the treatment of advanced primary or locally recurrent cancer. Careful patient selection and counseling are of paramount importance when considering someone for PE. Part of the evaluation process includes comprehensive assessment to exclude unresectable or metastatic disease. PE can be curative for carefully selected patients with gynecologic cancers. Major complications can be seen in as many as 50% of patients undergoing PE, underscoring the need to carefully discuss risks and benefits of this procedure with patients considering exenterative surgery.
全盆腔脏器切除术(PE)是一种根治性手术,包括整块切除盆腔器官,如生殖结构、膀胱和乙状结肠直肠。在妇科肿瘤学中,它最常用于治疗晚期原发性或局部复发性癌症。在考虑对某人进行全盆腔脏器切除术时,仔细的患者选择和咨询至关重要。评估过程的一部分包括全面评估以排除不可切除或转移性疾病。对于精心挑选的妇科癌症患者,全盆腔脏器切除术可能具有治愈效果。接受全盆腔脏器切除术的患者中多达50%会出现严重并发症,这突出表明需要与考虑进行脏器切除手术的患者仔细讨论该手术的风险和益处。